Compare VTRS & IOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTRS | IOT |
|---|---|---|
| Founded | 1961 | 2015 |
| Country | United States | United States |
| Employees | 30000 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7B | 18.5B |
| IPO Year | 2019 | 2021 |
| Metric | VTRS | IOT |
|---|---|---|
| Price | $17.31 | $38.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $13.50 | ★ $45.42 |
| AVG Volume (30 Days) | ★ 9.1M | 5.3M |
| Earning Date | 05-07-2026 | 06-04-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | ★ 92.86 |
| EPS | ★ 0.15 | 0.08 |
| Revenue | ★ $14,299,900,000.00 | $1,618,635,000.00 |
| Revenue This Year | $4.41 | $23.00 |
| Revenue Next Year | $1.96 | $19.69 |
| P/E Ratio | ★ $115.50 | $469.88 |
| Revenue Growth | N/A | ★ 29.57 |
| 52 Week Low | $8.63 | $23.38 |
| 52 Week High | $17.53 | $47.47 |
| Indicator | VTRS | IOT |
|---|---|---|
| Relative Strength Index (RSI) | 64.85 | 66.87 |
| Support Level | $15.82 | $35.78 |
| Resistance Level | N/A | $39.92 |
| Average True Range (ATR) | 0.45 | 2.23 |
| MACD | 0.09 | 0.28 |
| Stochastic Oscillator | 82.13 | 86.76 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers range from small and medium-sized businesses to state and local governments.